Evidence map›Paper›PMID 39600184›Full record

ArticleKorean journal of family medicine2024

Long COVID: A Comprehensive Overview of the Signs and Symptoms across Multiple Organ Systems.

Zachary Isaac Merhavy, Tiana Junor, Aranice Gonzalez, Samantha Michelle De Filippis, Sarah Oveisitork, Eliu Rivera, Ifeanyi Ndukwu, Kanika Bhatara

Abstract read
In one paragraph

Article in Korean journal of family medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Cognitive impairment in long-COVID: frequency, trajectories and risk factors in a cohort study from Italy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Zachary Isaac MerhavyRoss University School of Medicine, Bridgetown, Barbados.
Tiana JunorUniversity of Medicine and Health Sciences, Basseterre, St. Kitts & Nevis.
Aranice GonzalezUniversity of Medicine and Health Sciences, Basseterre, St. Kitts & Nevis.
Samantha Michelle De FilippisUniversity of Medicine and Health Sciences, Basseterre, St. Kitts & Nevis.
Sarah OveisitorkSt. George's University, True Blue, Grenada.
Eliu RiveraUniversity of Medicine and Health Sciences, Basseterre, St. Kitts & Nevis.
Ifeanyi NdukwuUniversity of Medicine and Health Sciences, Basseterre, St. Kitts & Nevis.
Kanika BhataraDepartment of Family Medicine, Wayne State University School of Medicine, Rochester, MI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long coronavirus disease (COVID), also known as the post-acute sequelae of coronavirus disease 2019 (COVID-19) (PASC), is a significant concern since the end of the COVID-19 pandemic, as it still manifests in individuals with persistent symptoms and complications beyond the acute phase of infection. Defining this disease is challenging, as it manifests as a spectrum of symptoms varying in severity among individuals who have previously tested positive for COVID-19. Long COVID is more prevalent in hospitalized COVID-19 patients and presents in various ways, ranging from pulmonary to extrapulmonary symptoms. This literature review examines the current body of research on long COVID with a focus on its effects on the cardiovascular, hematological, respiratory, renal, and neurological systems with systematically analyzed, peer-reviewed articles retrieved from the PubMed database. There have been several proposed pathophysiological mechanisms by which severe acute respiratory syndrome coronavirus 2 affects the aforementioned organ systems; however, research on the definite mechanisms is lacking, especially when considering the management of long COVID in the perioperative setting. The impact of post-COVID sequelae necessitates individualized management strategies tailored to each symptomatic profile, particularly in patients with comorbidities. The COVID-19 pandemic affected millions of people and had a profound impact on those who developed PASC, lowering their quality of life and increasing potential surgical risks. However, there is still uncertainty regarding the specific risk factors for long COVID and who is most susceptible to it. Further research is required to fill these gaps and explore potential avenues for preventing PASC.

Indexed as

CardiologyCOVIDEpidemiologyHematologyLong COVIDNephrologyPulmonology

Identifiers

PMID39600184
PMCPMC11605154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.